Dollar amounts in USD unless otherwise notedCompany closes inaugural issuance of $400 million of 5-year 3.85% senior unsecured investment-grade notes […]
MONMOUTH JUNCTION, N.J., June 03, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the Company), a late clinical-stage biopharmaceutical company working to […]